CTOs on the Move

Nanoscope Therapeutics

www.nanostherapeutics.com

 
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.

RetireeFirst

Established in 2005 and currently servicing over 250 clients, RetireeFirst (formerly LaborFirst) is the premier retiree benefit management solutions and advocacy service provider, proven to enhance the experience and outcomes for group plan sponsors, employers, and their retirees. Our sole focus on retiree benefits means our solutions and services, combined with our people-centric approach, deliver immediate savings, significantly reduce administrative burden, and help preserve the benefits retirees deserve. Our unparalleled retiree advocacy service connects members to programs that help improve their health and wellness, resulting in happier and more engaged members. We go above and beyond for our clients, and our Advocates give retirees a guiding hand to navigate their entire healthcare and benefits journey—ensuring peace of mind.

Trinity Health

Trinity Health is a nonprofit, integrated care system serving northwest/central North Dakota and Eastern Montana. With a tertiary care hospital in Minot, close to a dozen rural health clinics, and a long-term care facility, Trinity provides a full complement of healthcare services to the region.

BENU Inc

BENU Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in San Mateo, CA. To find more information about BENU Inc, please visit www.benu.com

Patient Focus Systems

Patient Focus Systems is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.